Progressive MS publications

Papers and presentations from the Progressive MS program.

2 items

All publications and presentations

September 2022
Peer-reviewed
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosisMultiple Sclerosis JournalView source
May 2019
Presentation
Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous MSC-NTF cells in progressive multiple sclerosis2019 Annual CMSC MeetingView source

BrainStorm's autologous MSC-NTF cell therapy (NurOwn^®, debamestrocel) is investigational and has not been approved by the FDA or any other regulatory authority.